Guenther, L.; Potts Bleakman, A.; Weisman, J.; Poulin, Y.; Spelman, L.; Burge, R.; Erickson, J.; Todd, K.; Bertram, C. C.; Ryan, C. Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial. Acta Derm Venereol 2020, 100, 1-9.